title: Re: OnabotulinumtoxinA improves health-related quality of life in patients with urinary incontinence due to idiopathic overactive bladder: a 36-week, double-blind, placebo-controlled, randomized, dose-ranging trial.
authors.forename: Alan J
authors.initials: AJ
authors.lastname: Wein